Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 482
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,463 Results (Page 5 of 124)
- Relevance
  Sort by

Global Hepatitis Therapeutics Market 2030 by Hepatitis Type, Drug Class, Drug Type, End-user and Distribution Channel and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints

 Report
August 2023
180 Pages
Global

From

€3725EUR$3,750USD£3,097GBP

Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

 Report
April 2020
536 Pages
Global

From

€4867EUR$4,899USD£4,047GBP

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
92 Pages
Global

From

€3477EUR$3,500USD£2,891GBP

Skin Cancer Drugs Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

U.S. Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing: Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030

 Report
September 2024
116 Pages
United States

From

€2479EUR$2,495USD£2,061GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Urinary Tract Infection Market by Clinical Indication, Treatment, End User - Global Forecast 2025-2030

 Report
October 2024
194 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

Chronic Hepatitis B Market By Drug Class, By Gender, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

 Report
October 2022
290 Pages
Global

From

€3547EUR$3,570USD£2,949GBP

Hepatitis C Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
91 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

US Pharmaceutical Market Size and Forecast (2020 - 2030), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Vaccines, Biologics & Biosimilars, and Small Molecules)

 Report
January 2024
292 Pages
United States

From

€2469EUR$2,485USD£2,053GBP

€3527EUR$3,550USD£2,932GBP

Olanzapine Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

Kidney Cancer Drugs - Global Strategic Business Report

 Report
November 2024
148 Pages
Global

From

€5414EUR$5,450USD£4,502GBP

Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-2027

 Report
November 2022
119 Pages
Global

From

€3924EUR$3,950USD£3,263GBP

HIV Drugs Market Report and Forecast 2023-2031

 Report
May 2023
160 Pages
Global

From

€5960EUR$5,999USD£4,955GBP

Diabetic Nephropathy Treatment Market by Treatment Type, End-User - Global Forecast 2025-2030

 Report
October 2024
181 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

Advanced Renal Cell Carcinoma Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
March 2022
99 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Hepatitis B Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2023
93 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Hepatitis Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2023
90 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Anxiolytics - Global Strategic Business Report

 Report
November 2024
78 Pages
Global

From

€5563EUR$5,600USD£4,626GBP

Ovarian Cancer Therapeutics - Global Strategic Business Report

 Report
November 2024
118 Pages
Global

From

€5414EUR$5,450USD£4,502GBP

Intravenous Iron Drugs Market by Product, Application - Global Forecast 2025-2030

 Report
October 2024
195 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

2,463 Results (Page 5 of 124)
- 1
- 3
- 4
- 5
- 6
- 7

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.